Currently, there are 169.80M common shares owned by the public and among those 83.19M shares have been available to trade.
The company’s stock has a 5-day price change of -21.73% and -34.53% over the past three months. DNUT shares are trading -28.20% year to date (YTD), with the 12-month market performance down to -45.86% lower. It has a 12-month low price of $8.34 and touched a high of $17.84 over the same period. DNUT has an average intraday trading volume of 1.73 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -19.15%, -22.33%, and -32.78% respectively.
Institutional ownership of Krispy Kreme Inc (NASDAQ: DNUT) shares accounts for 57.57% of the company’s 169.80M shares outstanding.
It has a market capitalization of $1.21B and a beta (3y monthly) value of 1.33. The stock’s trailing 12-month PE ratio is 43.85, while the earnings-per-share (ttm) stands at $0.16. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.42% over the week and 4.36% over the month.
Analysts forecast that Krispy Kreme Inc (DNUT) will achieve an EPS of -0.05 for the current quarter, -0.01 for the next quarter and 0.31 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.06 while analysts give the company a high EPS estimate of -0.06. Comparatively, EPS for the current quarter was 0.07 a year ago. Earnings per share for the fiscal year are expected to increase by 83.98%, and 72.30% over the next financial year.
Looking at the support for the DNUT, a number of firms have released research notes about the stock. Morgan Stanley stated their Equal-Weight rating for the stock in a research note on November 05, 2024, with the firm’s price target at $14. Evercore ISI coverage for the Krispy Kreme Inc (DNUT) stock in a research note released on August 27, 2024 offered a In-line rating with a price target of $13. HSBC Securities was of a view on July 23, 2024 that the stock is Buy, while Truist gave the stock Buy rating on June 10, 2024, issuing a price target of $13- $15. JP Morgan on their part issued Overweight rating on June 03, 2024.
